Earth Science Tech, Inc. (ETST) Announces 2022

Miami, FL, Jan. 10, 2023 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently in compounding pharmaceuticals and telemedicine, today announced its 2022. achievements.

ETST currently holds three wholly owned subsidiaries: Earth Science Foundation, Inc. (“ESF”), Peaks Curative, LLC. (“Peaks”), and, LLC. (“RxCompound”). ESF is structured to accept grants and donations for those in need. Peaks is telemedicine referral site facilitating asynchronous consultations for branded compound medications prepared by RxCompound. RxCompound is an innovative compounding pharmacy.

2022 Highlights:

  • ETST retired approximately $1,118,334 of its debt, 47% of the Company’s liabilities subsequently from the period ending September 30, 2022, reported 10-Q and will be reflected in the third quarter fiscal 2023 ended period ending December 31, 2022’s 10-Q.

(view filed 8-K)

  • ETST consummated mergers with its 2 candidates, RxCompound and Peaks, from its November 7, 2021, executed agreement, subsequently amended on November 8, 2022. Both RxCompound and Peaks have approximately 75 days from the date of consummation to complete their respective PCAOB audits to transition their books and operations into the Company.

(view filed 8-K)

  • ETST secured funding within the month of October 2022 for operations up to the date the Company achieves cash flow positive status.

(view filed 8-K)

  • RxCompound’s hazardous compounding room commenced operations within the month of December 2022 improving sales by increasing product offerings.
  • ETST received Peaks’ audited financials on December 29, 2022, pursuant to the consummation dated November 8, 2022.

(view filed 8-K)

  • RxCompound expanded its dispensing network from 2 states, Florida, and New York, to 6, by obtaining licenses in the states of Colorado, New Jersey, Rhode Island, and Arizona.
  • Peaks has commenced testing of its website’s upgrades after successfully launching the first version in June 2022. The updated site will offer generic versions of both Cialis and Viagra along with other compounded varieties of Tadalafil and Sildenafil, including its popular Tadalafil gummies.
  • RxCompound revamped its website within the month of December 2022.

About Earth Science Tech, Inc. (ETST)

Earth Science Tech, Inc. (“ETST”) a holding entity currently in compounding pharmaceuticals and telemedicine through its wholly owned subsidiaries, LLC and Peaks Curative, LLC.

To learn more, please visit:

About, LLC., LLC. (“RxCompound”), is an innovative Miami-based compounding pharmacy that was founded by physicians practicing wellness medicine and longevity.
To learn more please visit:

About Peaks Curative, LLC.

Peaks Curative, LLC. (“Peaks”), is the telemedicine referral site facilitating asynchronous consultations for branded compound medications prepared at RxCompound.

To learn more please visit:

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward. -looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact:
Nickolas S. Tabraue
CEO & Director
(786) 375-7281
[email protected]


Leave a Comment

Your email address will not be published. Required fields are marked *